Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bepotastine for Cough in Allergic Rhinitis
NCT04877678Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bepotastine in allergic rhinitis (AR), cough, sponsored by Asan Medical Center. Started Oct 2021; status: completed.
02
Drugs
bepotastine
03
Conditions
allergic rhinitis (AR)cough
Beyond the preview
Go deeper on NCT04877678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04877678.